KALPALATHA GUNTUPALLI to Treatment Outcome
This is a "connection" page, showing publications KALPALATHA GUNTUPALLI has written about Treatment Outcome.
Connection Strength
0.084
-
A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med. 2013 Mar; 41(3):706-16.
Score: 0.033
-
Critically ill obstetric patients in an American and an Indian public hospital: comparison of case-mix, organ dysfunction, intensive care requirements, and outcomes. Intensive Care Med. 2005 Aug; 31(8):1087-94.
Score: 0.019
-
Clinical aspects of asthma. Curr Opin Pulm Med. 1996 Jan; 2(1):60-5.
Score: 0.010
-
A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care. 2010; 14(3):R125.
Score: 0.007
-
Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med. 2008 Apr; 36(4):1083-8.
Score: 0.006
-
Hypotension is a predictor of mortality in acute exacerbations of chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci. 2007 Jan-Mar; 49(1):13-8.
Score: 0.005
-
Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med. 2004 Jan; 32(1):13-20.
Score: 0.004